Yonkers, NY, United States of America

Melvin J Boroshok

This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 1978.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1978

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Melvin J Boroshok: Innovator in Microencapsulation Technology

Introduction

Melvin J Boroshok is a notable inventor based in Yonkers, NY (US). He has made significant contributions to the field of microencapsulation, particularly through his innovative processes that enhance the quality and usability of ethylcellulose microcapsules.

Latest Patents

One of his key patents is titled "Process of isolating cyclohexane-free ethylcellulose microcapsules." This invention addresses the challenges associated with ethylcellulose walled microcapsules that are heavily solvated with cyclohexane, which can lead to clumping even after drying. By displacing cyclohexane with pentane, hexane, heptane, or octane during the isolation process, Boroshok's method produces a dry product consisting entirely of discrete dry microcapsules. This advancement has important implications for various applications in pharmaceuticals and other industries.

Career Highlights

Melvin J Boroshok is associated with Merck & Co., Inc., a leading global healthcare company. His work at Merck has allowed him to focus on innovative solutions that improve product formulations and delivery systems. His expertise in microencapsulation has positioned him as a valuable asset in the research and development sector.

Collaborations

Throughout his career, Boroshok has collaborated with esteemed colleagues, including Lewis D Morse and Roy W Grabner. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Melvin J Boroshok's contributions to the field of microencapsulation through his patented processes demonstrate his commitment to advancing technology in the pharmaceutical industry. His work continues to influence the development of effective drug delivery systems.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…